Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage Markers.

Wilsker DF, Barrett AM, Dull AB, Lawrence SM, Hollingshead MG, Chen A, Kummar S, Parchment RE, Doroshow JH, Kinders RJ.

Clin Cancer Res. 2019 May 15;25(10):3084-3095. doi: 10.1158/1078-0432.CCR-18-2523. Epub 2019 Feb 21.

PMID:
30792217
2.

The root causes of pharmacodynamic assay failure.

Ferry-Galow KV, Makhlouf HR, Wilsker DF, Lawrence SM, Pfister TD, Marrero AM, Bigelow KM, Yutzy WH, Ji JJ, Butcher DO, Gouker BA, Kummar S, Chen AP, Kinders RJ, Parchment RE, Doroshow JH.

Semin Oncol. 2016 Aug;43(4):484-91. doi: 10.1053/j.seminoncol.2016.06.006. Epub 2016 Jun 15. Review.

PMID:
27663480
3.

Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn.

Israel EJ, Wilsker DF, Hayes KC, Schoenfeld D, Simister NE.

Immunology. 1996 Dec;89(4):573-8.

Supplemental Content

Loading ...
Support Center